4.7 Letter

Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro

Journal

LEUKEMIA
Volume 28, Issue 12, Pages 2403-2406

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2014.235

Keywords

-

Funding

  1. NCI NIH HHS [P30 CA091842, P01CA101937, P01 CA101937, P30CA91842, R01 CA162086, R01CA162086] Funding Source: Medline
  2. NHLBI NIH HHS [K08 HL116605, K08HL116605] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available